Catalyst Wire Dossier Catalyst Wire Dossier

[68Ga]Ga-NOTA-RF

Ga-68 NOTA-RF radiopharmaceutical targeting RFVT3 · Peking Union Medical College Hospital
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for [68Ga]Ga-NOTA-RF, covering 2025-11-28 to 2025-11-28. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Evaluation of [68Ga]Ga-NOTA-RF PET Imaging Targeting RFVT3 in Patients With Pituitary Tumors [EARLY_Phase 1]

See pricing